Disc Medicine (IRON) Other Non Operating Income (2021 - 2026)
Disc Medicine's (IRON) quarterly Other Non Operating Income came in at $22000.0 in Q1 2026, up 833.33% year-on-year from $2357.1 in Q1 2025, and up 1200.0% on a QoQ basis from -$2000.0 in Q4 2025.
Disc Medicine (IRON) Other Non Operating Income (2021 - 2026) Analysis & Trends
Disc Medicine (IRON) has 6 years of Other Non Operating Income data on file, last reported at $22000.0 in Q1 2026.
- On a quarterly basis, Other Non Operating Income rose 833.33% year-over-year to $22000.0 in Q1 2026; TTM through Mar 2026 was $70000.0, a 1850.0% increase from a year earlier, with the FY2025 full-year figure at $45000.0, up 2350.0% from the prior year.
- Other Non Operating Income for Q1 2026 stood at $22000.0, up from -$2000.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for IRON reached as high as $100000.0 in Q1 2022 and fell as low as -$5.9 million in Q3 2022.
- Historically, Other Non Operating Income has averaged -$412642.9 across 5 years, with a median of -$1500.0 in 2024.
- Across the five-year window, Other Non Operating Income slumped 300.0% in 2025 and jumped 833.33% in 2026, its largest moves.
- Year by year, Other Non Operating Income stood at -$5.9 million in 2022, then soared by 99.83% to -$10000.0 in 2023, then soared by 130.0% to $3000.0 in 2024, then plunged by 166.67% to -$2000.0 in 2025, then surged by 1200.0% to $22000.0 in 2026.
- Per Business Quant data, the three most recent Other Non Operating Income figures were $22000.0 in Q1 2026, -$2000.0 in Q4 2025, and -$18000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - |
| 4 | BeOne Medicines | 471.51 Bn | 466.72 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.70 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn |
| 10 | Disc Medicine | 2.89 Bn | 2.89 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22,000.00 |
| Dec 31, 2025 | -2,000.00 |
| Sep 30, 2025 | -18,000.00 |
| Jun 30, 2025 | 68,000.00 |
| Mar 31, 2025 | -3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 9,000.00 |
| Jun 30, 2024 | -13,000.00 |
| Mar 31, 2024 | -1,000.00 |
| Dec 31, 2023 | -10,000.00 |
| Sep 30, 2023 | 13,000.00 |
| Jun 30, 2023 | -5,000.00 |
| Sep 30, 2022 | -5.94 Mn |
| Mar 31, 2022 | 100,000.00 |
| Dec 31, 2021 | -5.05 Mn |